Multiplex Molecular Assays
De-risking the Preclinical-to-Clinical Transition
With over 15+ years in genomic and transcriptomic profiling we can help you build proactive safety nets into your protocol from day one to facilitate the transition from preclinical to early clinical trial success. We advise on low-cost sample collection protocols that enable post-hoc advanced analyses for:
Investigating unexpected adverse events (AEs).
Identifying characteristics of patient responders.
Supporting MoA understanding to inform the next phase of research.
Our services cover a variety of protocol development aspects including; sample collection methods, multiplex panel design (DNA, RNA, or protein), and lab SOPs.
Mobile Software Solutions
Prioritizing Patient Safety and Adherence in At-Home Trials
We'll get back to you shortly.